fr 109615 has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ezaki, M; Fujie, A; Hashimoto, S; Imanaka, H; Inamoto, Y; Iwamoto, T; Kawabata, K; Kohsaka, M; Okuhara, M; Tsujii, E | 1 |
| Hirano, M; Kamei, H; Numata, K; Oki, T; Tomatsu, K | 1 |
2 other study(ies) available for fr 109615 and Candidiasis
| Article | Year |
|---|---|
FR109615, a new antifungal antibiotic from Streptomyces setonii. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity.
Topics: Animals; Antifungal Agents; Candida; Candidiasis; Cycloleucine; Female; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred ICR; Molecular Structure; Spectrophotometry, Infrared; Streptomyces | 1990 |
Cispentacin, a new antifungal antibiotic. II. In vitro and in vivo antifungal activities.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Cycloleucine; Drug Evaluation, Preclinical; Flucytosine; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1989 |